Header Logo

Connection

LEI NIE to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications LEI NIE has written about Drug Evaluation, Preclinical.
LEI NIE
Connection Strength
0.027
Drug Evaluation, Preclinical
  1. FDA approval: siltuximab for the treatment of patients with multicentric Castleman disease. Clin Cancer Res. 2015 Mar 01; 21(5):950-4.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.